 |
deflazacort |
|---|---|
| Trade Name | |
| Orphan Indication | Pediatric (0 through 16 years of age) juvenile idiopathis arthritis (JIA) International League of Associations for Rheumatology (ILAR) categories excluding systemic JIA |
| USA Market Approval | USA |
| USA Designation Date | 2015-10-22 00:00:00 |
| Sponsor | PTC Therapeutics, Inc.;100 Corporate Court;South Plainfield, New Jersey, 07080 |
